跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CAN 296
首页
药物
CAN 296
CAN 296
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Therapeutic combination of a pneumocandin derivative and an antifungal agent
US 7375081 B2
申请人: ASTELLAS PHARMA INC
优先权: 1999
US
3 件公开
Neuronal cell model and methods of use thereof
US 2003032006 A1
申请人: MILLER CRAIG S
优先权: 2001
US
2 件公开
Human miR-296-5p antisense nucleic acid and application thereof
CN 101993877 A
申请人: SUZHOU GENEPHARMA CO LTD
优先权: 2009
CN
Application of ING4 and IL-24 double-gene coexpression vector as radiotherapy sensitizing agent
CN 101912619 A
申请人: UNIV SUZHOU
优先权: 2010
CN
Application of miR-296-3p to preparation of kit for diagnosing prostate cancer generation or migration
CN 102965439 A
申请人: SHANGHAI JIAOTONG UNIV SCHOOL MEDICINE
优先权: 2012
CN
Kits for administering and tracking administration of oral chews to animals and uses and methods of using same
CN 121336938 A
申请人: MARS INC
优先权: 2019
CN
Bovine rotavirus fusion protein and calf diarrhea multivalent vaccine
US 11952400 B2
申请人: TECON BIOPHARMACEUTICAL CO LTD
优先权: 2020
US
Artificial active peptide for promoting cartilage repair as well as preparation method and application of artificial active peptide
CN 117843728 A
申请人: LI HONGFANG
优先权: 2023
CN
Antibody MesoR11 targeting human mesothelin, CAR-T cell based on antibody and application
CN 118085095 A
申请人: SUZHOU TONGQIAN MEDICAL TECH CO LTD
优先权: 2024
CN
RNA BIOMARKERS FOR USE IN TREATING, DIAGNOSING, AND MONITORING COLORECTAL CANCER AND COLORECTAL ADENOMA
WO 2026050199 A1
申请人: HOPE CITY
优先权: 2024
WO
第 1 / 2 页
上一页
下一页
药物
反馈